- Public Comps
- FluoGuide
FluoGuide Valuation Multiples
Discover revenue and EBITDA valuation multiples for FluoGuide and similar public comparables like Senzime, Sensus Healthcare, Daxor, K Pharma and more.
FluoGuide Overview
About FluoGuide
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
Founded
2018
HQ

Employees
8
Website
Financials (LTM)
EV
$55M
Valuation Multiples
Start free trialFluoGuide Financials
FluoGuide reported last 12-month revenue of $11K and negative EBITDA of ($8M).
In the same LTM period, FluoGuide generated $11K in gross profit, ($8M) in EBITDA losses, and had net loss of ($8M).
Revenue (LTM)
FluoGuide P&L
In the most recent fiscal year, FluoGuide reported revenue of - and EBITDA of ($7M).
FluoGuide is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.
Financial data powered by Morningstar, Inc.
FluoGuide Stock Performance
FluoGuide has current market cap of $58M, and enterprise value of $55M.
Market Cap Evolution
FluoGuide's stock price is $3.57.
FluoGuide share price decreased by 14.4% in the last year.
FluoGuide has an EPS (earnings per share) of $-0.38.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55M | $58M | -0.4% | 0.0% | -17.4% | -14.4% | $-0.38 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFluoGuide Valuation Multiples
FluoGuide trades at 4799.6x EV/Revenue multiple, and (7.0x) EV/EBITDA.
FluoGuide Financial Valuation Multiples
As of September 1, 2026, FluoGuide has market cap of $58M and EV of $55M.
FluoGuide has a P/E ratio of (7.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified FluoGuide Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


FluoGuide Margins & Growth Rates
FluoGuide grew EBITDA by 27% in the last fiscal year.
FluoGuide Margins
FluoGuide Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
FluoGuide Operational KPIs
FluoGuide's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.8M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
FluoGuide Competitors
FluoGuide competitors include Senzime, Sensus Healthcare, Daxor, K Pharma, Myomo, Chandan Healthcare, Theraclion, Vuno, TeraView Holdings and Envoy Medical.
Most FluoGuide public comparables operate across Medical Devices, Medical Imaging & Diagnostics, BioTech, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.2x | 4.4x | (4.7x) | (8.0x) | |||
| 1.6x | 2.0x | (4.5x) | (4.5x) | |||
| 5.7x | 8.8x | - | - | |||
| - | - | (8.8x) | - | |||
| 1.6x | 1.5x | (5.2x) | (8.4x) | |||
| 2.6x | - | 14.2x | - | |||
| 42.7x | - | (8.5x) | - | |||
| 1.5x | - | (14.3x) | - | |||
This data is available for Pro users. Sign up to see all FluoGuide competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout FluoGuide
| When was FluoGuide founded? | FluoGuide was founded in 2018. |
| Where is FluoGuide headquartered? | FluoGuide is headquartered in Denmark. |
| How many employees does FluoGuide have? | As of today, FluoGuide has over 8 employees. |
| Is FluoGuide publicly listed? | Yes, FluoGuide is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of FluoGuide? | FluoGuide trades under FLUO ticker. |
| When did FluoGuide go public? | FluoGuide went public in 2019. |
| Who are competitors of FluoGuide? | FluoGuide main competitors include Senzime, Sensus Healthcare, Daxor, K Pharma, Myomo, Chandan Healthcare, Theraclion, Vuno, TeraView Holdings, Envoy Medical. |
| What is the current market cap of FluoGuide? | FluoGuide's current market cap is $58M. |
| What is the current revenue of FluoGuide? | FluoGuide's last 12 months revenue is $11K. |
| What is the current revenue growth of FluoGuide? | FluoGuide revenue growth (NTM/LTM) is (50%). |
| What is the current EV/Revenue multiple of FluoGuide? | Current revenue multiple of FluoGuide is 4799.6x. |
| Is FluoGuide profitable? | No, FluoGuide is not profitable. |
| What is the current EBITDA of FluoGuide? | FluoGuide has negative EBITDA and is not profitable. |
| What is FluoGuide's EBITDA margin? | FluoGuide's last 12 months EBITDA margin is (69055%). |
| What is the current EV/EBITDA multiple of FluoGuide? | Current EBITDA multiple of FluoGuide is (7.0x). |
| How many companies FluoGuide has acquired to date? | FluoGuide hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies FluoGuide has invested to date? | FluoGuide hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to FluoGuide
Lists including FluoGuide
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




